Navigation Links
Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
Date:9/24/2009

,392,639 $1,337,682 Short-term bank loans 1,399,075 1,393,345 VAT taxes payable 458,930 277,090 Income taxes payable 490,514 341,214 Other taxes payable 11,890 39,939 Dividends payable 325,417 378,545 Other current liabilities 307,934 142,733 Total current liabilities 4,386,399 3,910,548 Total liabilities 4,386,399 3,910,548 Stockholders' equity: Common stock, $0.001 par value, 50,000,000 shares authorized, 17,908,912 and 14,738,450 shares issued and outstanding at June 30, 2009 and 2008, respectively 17,909 14,739 Series A convertible preferred stock, $0.001 par value, 7,146,500 and 9,384,375 shares issued and outstanding at June 30, 2009 and 2008, respectively 7,147 9,384 Additional paid-in capital 19,694,514 18,002,439 Statutory reserve 2,299,807 1,380,806 Treasury stock (111,587) -- Retained earnings 16,486,775 10,963,131 Accumulated other comprehensive income 2,551,380 2,477,874 Total stockholders' equity 40,945,945 32,848,373 Total liabilities and stockholders' equity $45,322,344 $36,758,921

Consolidated Statements of Operations and Comprehensive Income

                                                   For the Years Ended June 30,
                                                        2009  
'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
2. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
5. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
6. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
7. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
8. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
9. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
10. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
11. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015  Renova™ Therapeutics, a biopharmaceutical company developing ... other chronic diseases, has engaged RAND Health Advisory ... reflect the healthcare patterns of multiple advanced heart ... used to characterize the impact the company,s lead ... groups of patients and the overall health care ...
(Date:5/5/2015)... , May 5, 2015 ImmunoCellular Therapeutics, ... Andrew Gengos , President and Chief Executive Officer, ... 2015. DATE:  Thursday, May 7, 2015     ... http://VirtualInvestorConferences.com > click the red "register/ watch ... live, interactive online event where investors are invited ...
(Date:5/5/2015)... BELLINGHAM, Washington, and WASHINGTON, D.C., USA (PRWEB) May 05, ... today on U.S. export regulations covering a wide range ... the industry say are hampering global competitiveness of U.S. ... will host a webinar on 12 May ... Category XII, which governs the commodities covered by International ...
(Date:5/5/2015)... May 05, 2015 Research and Markets ... of the "Clinical Laboratory, Molecular Diagnostics and ... to 2019 - Global Version" report to ... in the area of molecular diagnostics and pharmacogenics ... evolving world market that is moving out of ...
Breaking Biology Technology:RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2
... - Sales Up 15% - Non-GAAP Operating Earnings Up ... - Non-GAAP Diluted EPS Up 29%, ... 29 Varian, Inc.,(NasdaqGS: VARI) today reported fourth fiscal quarter ... revenues of $245.6,million in the fourth quarter of fiscal year ...
... BEDFORD, Mass., Oct. 29 Aware, Inc. (Nasdaq:,AWRE), a ... that its Board of Directors has approved an extension ... repurchase from,time to time at management,s discretion up to ... in the open market or in private until December,31, ...
... SEATTLE, Oct. 29 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ... an overview of the company at two upcoming industry ... 10th Annual Healthcare Conference at the,New York Palace Hotel, ... financial officer and senior vice president, is scheduled to ...
Cached Biology Technology:Varian, Inc. Reports Strong Fourth Quarter 2008 Results 2Varian, Inc. Reports Strong Fourth Quarter 2008 Results 3Varian, Inc. Reports Strong Fourth Quarter 2008 Results 4Varian, Inc. Reports Strong Fourth Quarter 2008 Results 5Varian, Inc. Reports Strong Fourth Quarter 2008 Results 6Varian, Inc. Reports Strong Fourth Quarter 2008 Results 7Varian, Inc. Reports Strong Fourth Quarter 2008 Results 8Varian, Inc. Reports Strong Fourth Quarter 2008 Results 9Varian, Inc. Reports Strong Fourth Quarter 2008 Results 10Varian, Inc. Reports Strong Fourth Quarter 2008 Results 11Varian, Inc. Reports Strong Fourth Quarter 2008 Results 12Varian, Inc. Reports Strong Fourth Quarter 2008 Results 13Varian, Inc. Reports Strong Fourth Quarter 2008 Results 14Varian, Inc. Reports Strong Fourth Quarter 2008 Results 15Varian, Inc. Reports Strong Fourth Quarter 2008 Results 16Varian, Inc. Reports Strong Fourth Quarter 2008 Results 17Varian, Inc. Reports Strong Fourth Quarter 2008 Results 18Varian, Inc. Reports Strong Fourth Quarter 2008 Results 19Varian, Inc. Reports Strong Fourth Quarter 2008 Results 20Varian, Inc. Reports Strong Fourth Quarter 2008 Results 21Varian, Inc. Reports Strong Fourth Quarter 2008 Results 22Varian, Inc. Reports Strong Fourth Quarter 2008 Results 23Varian, Inc. Reports Strong Fourth Quarter 2008 Results 24Varian, Inc. Reports Strong Fourth Quarter 2008 Results 25Varian, Inc. Reports Strong Fourth Quarter 2008 Results 26Varian, Inc. Reports Strong Fourth Quarter 2008 Results 27Aware, Inc. Announces Extension of Stock Repurchase Plan 2Trubion Announces Presentations at Upcoming Investor Conferences 2
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... critical security-authentication needs, today announced the beginning of shipments ... solution. The company, based in ... the three-day Connect:ID Expo, which began here today at ... said version 2.0 of its SDK boosts the accuracy ...
(Date:3/23/2015)... SoundView Technology Group issues a new research update following the ... wallet. SoundView was one of the selected user groups to provide ... in multiple scenarios and outlets. Soundview shares ... both debit and credit card payments.  Soundview ... meets their plans in 2015, it would push our IV ...
(Date:3/23/2015)... 2015  In the 2014 fiscal year, irs.gov recorded ... This figure accounts for a fraction of the estimated ... Report, exceeds $11 billion globally. The polygraph has traditionally ... has occurred. Investor Mark Saint Juste along ... Paolella partnered to administer the test in a ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... LA JOLLA, CAA key question in protein biochemistry is ... of cellular factors. Nowhere is that more critical to ... protein activity can alter an organism,s behavior. A team ... has recently deciphered a molecular code that regulates availability ...
... 2011 BGI (previously known as the Beijing Genomics ... its participation and pivotal role in the Earth Microbiome ... the functional and evolutionary diversity of microbial communities across ... mankind. Unlike past microbial studies that have ...
... million units of blood are transfused in the US every ... including Hepatitis B and C, HIV types 1 and 2, ... that has been linked to chronic fatigue syndrome. A symposium ... will reveal recent advances in the testing and screening of ...
Cached Biology News:Salk scientists crack molecular code regulating neuronal excitability 2Salk scientists crack molecular code regulating neuronal excitability 3BGI to Play Pivotal Sampling, Next-Generation Sequencing and Bioinformatics Role in Earth Microbiome Project 2BGI to Play Pivotal Sampling, Next-Generation Sequencing and Bioinformatics Role in Earth Microbiome Project 3BGI to Play Pivotal Sampling, Next-Generation Sequencing and Bioinformatics Role in Earth Microbiome Project 4
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Biology Products: